SILIPOS Holding LLC

Silipos Holding LLC is a specialized manufacturer of polymer gel foot care and therapeutic products with over 30 years of industry experience. The company develops innovative visco-elastic gel formulations designed to cushion, protect, and moisturize the foot and hand through proprietary gel technology. Silipos markets 16 distinct gel formulations across four primary segments: Active (athletic and high-performance use), Mobility (prosthetics and assistive applications), Wellness (general comfort and preventive care), and Medical (clinical foot conditions). Product lines address plantar fasciitis, metatarsal pain, general foot pain, swelling, skin conditions including eczema, prosthetic socket comfort, and sports-related injury prevention. The visco-elastic gel properties are engineered to move synergistically with skin to prevent abrasion, blister formation, and discomfort while providing moisture management. Distribution is primarily through established medical-surgical wholesalers including Medline Industries, McKesson Medical-Surgical, Henry Schein, Performance Health Supply, and specialized podiatry suppliers. As of March 2024, Silipos transitioned from direct-to-consumer e-commerce to a B2B distributor model, focusing on healthcare provider and retail channels. The company is headquartered in Niagara Falls, New York, and maintains full manufacturing and customer service operations. While specific FDA clearances or ISO certifications are not detailed on the public site, the product portfolio targets medical and clinical applications alongside consumer wellness markets. Silipos positions itself as a leader in gel innovation with proprietary formulation expertise and unmatched product quality in the therapeutic cushioning segment.